@Kokorache 8 months ago
FDA puts clinical hold on Regenxbio gene therapy programs
FDA puts clinical hold on Regenxbio gene therapy programs
Regenxbio said the FDA placed a clinical hold on two of their experimental gene therapy programs for rare childhood diseases. A brain tumor was found in one treated patient, so regulators paused the trials.
finance.yahoo.com
| US FDA places clinical hold on Regenxbio's gene therapy trials
There are no comments here, be the first to comment
